Advertisement
Research Article

Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species

  • Lisa E. Hensley equal contributor,

    equal contributor Contributed equally to this work with: Lisa E. Hensley, Sabue Mulangu

    Affiliation: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

    X
  • Sabue Mulangu equal contributor,

    equal contributor Contributed equally to this work with: Lisa E. Hensley, Sabue Mulangu

    Affiliation: Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Clement Asiedu,

    Affiliation: Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Joshua Johnson,

    Affiliation: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

    X
  • Anna N. Honko,

    Affiliation: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

    X
  • Daphne Stanley,

    Affiliation: Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Giulia Fabozzi,

    Affiliation: Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Stuart T. Nichol,

    Affiliation: Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Thomas G. Ksiazek,

    Affiliation: Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    Current address: University of Texas Medical Branch, Galveston National Laboratory, Galveston, Texas, United States of America

    X
  • Pierre E. Rollin,

    Affiliation: Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Victoria Wahl-Jensen,

    Affiliation: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America

    X
  • Michael Bailey,

    Affiliation: Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Peter B. Jahrling,

    Affiliation: Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Mario Roederer,

    Affiliation: Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Richard A. Koup,

    Affiliation: Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Nancy J. Sullivan mail

    nsullivan@nih.gov

    Affiliation: Biodefense Research Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Published: May 20, 2010
  • DOI: 10.1371/journal.ppat.1000904

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.